Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
Shudi Li; Fei Duan; Suling Li; Baoping Lu;
Ann Hepatol. 2024;29:
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study
Renling Yao; Sufang Lu; Ruifei Xue; Jian Wang; Yuanwang Qiu; Yuxin Chen; Jiacheng Liu; Li Zhu; Jie Zhan; Suling Jiang; Shengxia Yin; Xin Tong; Weimao Ding; Jie Li; Chuanwu Zhu; Rui Huang; Chao Wu;
Ann Hepatol. 2024;29: